Immunotherapy combination treatment strategies in PDAC

Role of tumor microenvironment as key barrier to immunotherapy efficacy and examine how immunotherapy biomarkers may be used to detect immunotherapy’s response.

Related Keywords

Yamaguchi ,Kanagawa ,Japan ,United States ,Kayahara ,Shimane ,Hiroshima ,Caod Toripalimab ,Van Hoeck ,Chenj Sindilimab ,Squibbbm Nivolumab ,Squibbbm Neoadjuvant ,Gastroenterol Hepatol ,Hopkins Skccca ,Squibbbm Ltd ,Japan Pancreas Society ,Research Aaf ,Astrazeneca ,Center Nio ,Universityz Combination ,Health Nio ,Rev Dis ,Pain Symptom ,Nat Clin Pract Gastroenterol ,Rev Clin ,Curr Drug ,Squibbb M ,Rev Gastroenterol ,Hum Vaccin ,Lub De Hooge ,Clin Cancer ,Cancer Metast ,Opin Genet ,Cancer Res Clin ,Hepatobiliary Pancreat Dis ,